skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

Douillard, J.Y. ; Siena, S. ; Cassidy, J. ; Tabernero, J. ; Burkes, R. ; Barugel, M. ; Humblet, Y. ; Bodoky, G. ; Cunningham, D. ; Jassem, J. ; Rivera, F. ; Kocákova, I. ; Ruff, P. ; Błasińska-Morawiec, M. ; Šmakal, M. ; Canon, J.L. ; Rother, M. ; Oliner, K.S. ; Tian, Y. ; Xu, F. ; Sidhu, R.

Annals of oncology, 2014-07, Vol.25 (7), p.1346-1355 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial
Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial

Howells, Lynne M ; Iwuji, Chinenye O O ; Irving, Glen R B ; Barber, Shaun ; Walter, Harriet ; Sidat, Zahirah ; Griffin-Teall, Nicola ; Singh, Rajinder ; Foreman, Nalini ; Patel, Samita R ; Morgan, Bruno ; Steward, William P ; Gescher, Andreas ; Thomas, Anne L ; Brown, Karen

The Journal of nutrition, 2019-07, Vol.149 (7), p.1133-1139 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma

Hadoux, J ; Malka, D ; Planchard, D ; Scoazec, J Y ; Caramella, C ; Guigay, J ; Boige, V ; Leboulleux, S ; Burtin, P ; Berdelou, A ; Loriot, Y ; Duvillard, P ; Chougnet, C N ; Déandréis, D ; Schlumberger, M ; Borget, I ; Ducreux, M ; Baudin, E

Endocrine-related cancer, 2015-06, Vol.22 (3), p.289-298 [Periódico revisado por pares]

England: Bioscientifica Ltd

Texto completo disponível

Citações Citado por
4
S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial
S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial

Yamada, Y. ; Denda, T. ; Gamoh, M. ; Iwanaga, I. ; Yuki, S. ; Shimodaira, H. ; Nakamura, M. ; Yamaguchi, T. ; Ohori, H. ; Kobayashi, K. ; Tsuda, M. ; Kobayashi, Y. ; Miyamoto, Y. ; Kotake, M. ; Shimada, K. ; Sato, A. ; Morita, S. ; Takahashi, S. ; Komatsu, Y. ; Ishioka, C.

Annals of oncology, 2018-03, Vol.29 (3), p.624-631 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database

Salem, M.E. ; Yin, J. ; Goldberg, R.M. ; Pederson, L.D. ; Wolmark, N. ; Alberts, S.R. ; Taieb, J. ; Marshall, J.L. ; Lonardi, S. ; Yoshino, T. ; Kerr, R.S. ; Yothers, G. ; Grothey, A. ; Andre, T. ; De Gramont, A. ; Shi, Q.

Annals of oncology, 2020-04, Vol.31 (4), p.480-486 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study
Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study

Pintova, Sofya ; Dharmupari, Sirish ; Moshier, Erin ; Zubizarreta, Nicole ; Ang, Celina ; Holcombe, Randall F.

Cancer chemotherapy and pharmacology, 2019-09, Vol.84 (3), p.591-598 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
7
First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)
First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)

Carrato, Alfredo ; Abad, Albert ; Massuti, Bartomeu ; Grávalos, Cristina ; Escudero, Pilar ; Longo-Muñoz, Federico ; Manzano, José-Luis ; Gómez, Auxiliadora ; Safont, María José ; Gallego, Javier ; García-Paredes, Beatriz ; Pericay, Carles ; Dueñas, Rosario ; Rivera, Fernando ; Losa, Ferrán ; Valladares-Ayerbes, Manuel ; González, Encarnación ; Aranda, Enrique

European journal of cancer (1990), 2017-08, Vol.81, p.191-202 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies
Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies

Del Rio, M ; Mollevi, C ; Bibeau, F ; Vie, N ; Selves, J ; Emile, J.-F ; Roger, P ; Gongora, C ; Robert, J ; Tubiana-Mathieu, N ; Ychou, M ; Martineau, P

European journal of cancer (1990), 2017-05, Vol.76, p.68-75 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study

Harding, James J. ; Yang, Tsai‐Sheng ; Chen, Yen‐Yang ; Feng, Yin‐Hsun ; Yen, Chia‐Jui ; Ho, Ching‐Liang ; Huang, Wen‐Tsung ; El Dika, Imane ; Akce, Mehmet ; Tan, Benjamin ; Cohen, Stacey A. ; Meyer, Timothy ; Sarker, Debashis ; Lee, Dae‐Won ; Ryoo, Baek‐Yeol ; Lim, Ho Yeong ; Johnston, Amanda ; Bomalaski, John S. ; O’Reilly, Eileen M. ; Qin, Shukui ; Abou‐Alfa, Ghassan K.

Cancer, 2021-12, Vol.127 (24), p.4585-4593 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
10
Retrospective Analysis of Definitive Chemoradiotherapy With FOLFOX in Patients With Esophageal Cancer Intolerant to Cisplatin
Retrospective Analysis of Definitive Chemoradiotherapy With FOLFOX in Patients With Esophageal Cancer Intolerant to Cisplatin
Material Type:
Artigo 		Adicionar ao Meu Espaço

Retrospective Analysis of Definitive Chemoradiotherapy With FOLFOX in Patients With Esophageal Cancer Intolerant to Cisplatin

Yada, Mayu ; Yamamoto, Shun ; Honma, Yoshitaka ; Hirano, Hidekazu ; Okita, Natsuko ; Shoji, Hirokazu ; Iwasa, Satoru ; Takashima, Atsuo ; Nagahara, Akihito ; Kato, Ken

In vivo (Athens), 2024-03, Vol.38 (2), p.761-766 [Periódico revisado por pares]

Greece: International Institute of Anticancer Research

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (160)
  2. Revistas revisadas por pares (177)

Data de Publicação 

De até
Refinar
  1. Antes de2007  (5)
  2. 2007Até2009  (33)
  3. 2010Até2012  (48)
  4. 2013Até2016  (58)
  5. Após 2016  (44)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (172)
  2. Japonês  (44)
  3. Mais opções open sub menu

Neste Assunto:

  1. Aged
  2. Humans
  3. Female
  4. Male
  5. Middle Aged

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.